Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...
Condition: Substance Abuse Interventions: Behavioral: Contingency Management; Behavioral: Probation as Usual Sponsors: Oregon Social Learning Center; George Mason University Recruiting
Condition: Problem Behavior Interventions: Behavioral: Idaho Rural Implementation Model; Behavioral: Control Sponsors: Boise State University; U.S. Department of Justice Recruiting
Conditions: Osteoarthritis; Arthritis; Avascular Necrosis; Fracture of the Femoral Neck or Head; Congenital Hip Dysplasia Intervention: Device: Mpact Acetabular Shell Sponsor: Medacta International SA Recruiting
Conditions: Intravenous Fluids; Fluid and Electrolyte Imbalance; ADH Inappropriate Intervention: Other: Education, clinical decision support tools Sponsors: Seattle Children's Hospital; American Academy of Pediatrics Active, not recruiting
Condition: Short Stature Children Born Small for Gestational Age (SGA) Interventions: Drug: somapacitan; Drug: Norditropin® Sponsor: Novo Nordisk A/S Recruiting
Condition: Myopia Interventions: Drug: Atropine; Other: Placebo Eyedrops Sponsors: Jaeb Center for Health Research; Pediatric Eye Disease Investigator Group; National Eye Institute (NEI) Recruiting
Condition: Hip Osteoarthritis Intervention: Device: Quadra®-H, Quadra®-C, AMIStem®-H or AMIStem®-C femoral stem and Mpact® Acetabular hip system with CoCr Femoral Head or Ceramic MectaCer BIOLOX® Femoral Head Sponsor: Medacta USA Recruiting
Condition: Acute Migraine With or Without Aura Interventions: Drug: sumatriptan nasal powder; Drug: Placebo Sponsor: Currax Pharmaceuticals Active, not recruiting
Condition: Amblyopia Interventions: Other: iPad®; Other: Spectacle correction Sponsors: Jaeb Center for Health Research; Pediatric Eye Disease Investigator Group; National Eye Institute (NEI) Recruiting
Condition: Intermittent Exotropia Interventions: Device: Overminus treatment; Device: Non-overminus treatment Sponsors: Jaeb Center for Health Research; Pediatric Eye Disease Investigator Group; National Eye Institute (NEI) Active, not recruiting
Condition: Myeloid Proliferations Associated With Down Syndrome Interventions: Other: Diagnostic Laboratory Biomarker Analysis; Other: Pharmacological Study Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Active, not recruiting
Conditions: Breast Carcinoma; Estrogen Receptor Negative; Progesterone Receptor Negative Interventions: Procedure: Screening Mammography; Procedure: Biospecimen Collection Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Recruiting
Condition: Cluster Detection Interventions: Other: Routine cluster detection; Other: Enhanced cluster detection Sponsors: Harvard Pilgrim Health Care; Hospital Corporation of America (HCA) Healthcare; Brigham and Women's Hospital; University of California, Irvine; Harvard School of Public Health; Rush University; Duke University; University of Massachusetts, Amherst; University of California, San Francisco; Cook County Health & Hospitals System; Centers for Disease Control and Prevention Recruiting
Condition: Staphylococcus Aureus Interventions: Drug: Arm 1. Routine Care (Mupirocin/CHG); Drug: Arm 2. Iodophor/CHG Decolonization Sponsors: Harvard Pilgrim Health Care; Hospital Corporation of America; University of California, Irvine; University of Massachusetts, Amherst; Rush University; Centers for Disease Control and Prevention Active, not recruiting
Conditions: Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma Interventions: Biological: Inotuzumab Ozogamicin; Other: Laboratory Biomarker Analysis; Other: Pharmacological Study Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Suspended
Condition: Juvenile Osteochondritis Dissecans Interventions: Procedure: Retro-articular drilling; Procedure: Trans-articular drilling Sponsors: Boston Children’s Hospital; Pediatric Orthopaedic Society of North America; University of Pennsylvania; Tennessee Orthopedic Alliance; Children's Hospital Medical Center, Cincinnati; Children's Hospital and Health System Foundation, Wisconsin; Washington University School of Medicine; The Hospital for Sick Children; Children's Hospital of Philadelphia; Kaiser Permanente; Rady Children's Hospital, San Diego; St. Luke's Children's Hospital; Medical College of Wisconsin; Connecticut Children's Medical Center; Hospital for Special Surgery, New York Active, not recruiting
Conditions: Central Nervous System Nongerminomatous Germ Cell Tumor; Childhood Central Nervous System Germinoma Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy; Drug: Carboplatin; Drug: Etoposide; Drug: Ifosfamide; Radiation: Intensity-Modulated Radiation Therapy Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Active, not recruiting
Conditions: Neurofibromatosis Type 1; Recurrent Childhood Pilocytic Astrocytoma; Recurrent Childhood Visual Pathway Glioma Interventions: Drug: Lenalidomide; Other: Pharmacological Study Sponsor: National Cancer Institute (NCI) Active, not recruiting
Conditions: Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q; Stage IV Wilms Tumor Interventions: Drug: doxorubicin hydrochloride; Drug: liposomal vincristine sulfate; Procedure: conventional surgery; Radiation: 3-dimensional conformal radiation therapy; Biological: dactinomycin; Drug: cyclophosphamide; Drug: etoposide Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Completed
Conditions: Brain Tumor; Central Nervous System Tumor Intervention: Radiation: radiation therapy Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Completed
Condition: Malignant Neoplasm Interventions: Other: Biospecimen Collection; Other: Questionnaire Administration Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Recruiting
Condition: Atopic Dermatitis Eczema Interventions: Drug: ALX-101 Gel Vehicle; Drug: ALX-101 Gel 5% Sponsor: Ralexar Therapeutics, Inc. Active, not recruiting
Conditions: Inflammatory Breast Cancer; Male Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer Interventions: Drug: sunitinib malate; Drug: paclitaxel; Drug: doxorubicin hydrochloride; Drug: cyclophosphamide; Biological: filgrastim; Procedure: therapeutic conventional surgery; Other: laboratory biomarker analysis; Other: flow cytometry Sponsors: University of Washington; National Cancer Institute (NCI) Completed
Conditions: Degenerative and Traumatic Pathology of the Knee; Degenerative and Traumatic Pathology of the Shoulder and Elbow; Degenerative and Traumatic Pathology of the Foot and Ankle; Degenerative and Traumatic Pathology of the Hand and Wrist; Degenerative and Traumatic Pathology of the Hip Intervention: Sponsor: Arthrex, Inc. Recruiting
Condition: Multiple Myeloma Interventions: Drug: Lenalidomide; Drug: lenalidomide, bortezomib and dexamethasone Sponsors: National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant Clinical Trials Network; National Cancer Institute (NCI) Completed
Condition: Osteosarcoma Intervention: Other: Cytology Specimen Collection Procedure Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Active, not recruiting